Figure 4
Figure 4. Engraftment and expansion of TK+ lymphocytes in NOD/Scid mice that received a transplant of allogeneic human skin. NOD/Scid mice received a transplant of human skin (day 0), and were conditioned with anti-NK antibodies (day 10) and sublethal irradiation (day 11) prior to the intravenous infusion of TK+ lymphocytes or PBLs (day 11). TK+ lymphocytes infused to mice were transduced with optimized Mut2-SFCMM3 vector, enabling a transduction efficiency higher than 30% in all conditions. (A) Kinetics of human chimerism calculated as [% of circulating human CD3+ lymphocytes]/[(% of circulating murine CD45+ cells) + (% of circulating human CD3+ lymphocytes)] are shown. baCD3/CD28+ IL-7/IL-15 (■), baCD3/CD28+ IL-7 (), baCD3/CD28+ IL-2 (), aCD3+ IL-2 (□), or PBLs (). Medians of 8 independent experiments with 13 different donor cells are shown. *P < .05; **P < .01. WBC indicates white blood cells. (B) At weeks 1 and 2 after lymphocyte infusion, CD4/CD8 ratio was analyzed on circulating human CD3 lymphocytes. baCD3/CD28+ IL-7/IL-15 (■), baCD3/CD28+ IL-7 (), baCD3/CD28+ IL-2 (), aCD3+ IL-2 (□), or PBLs (). Averages plus or minus SD of 6 independent experiments with 11 different donor cells are shown. *P < .05. (C) At weeks 1 and 2 after lymphocyte infusion, human CD3+ lymphocytes were analyzed by flow cytometry for CD45RA and CD62L expression. Percentages of circulating human TCM (CD45RA−CD62L+) and TEM (CD45RA−CD62L−) T lymphocytes were measured in mice that received a transplant of baCD3/CD28+ IL-7/IL-15 TK+ lymphocytes (♦), baCD3/CD28+ IL-7 TK+ lymphocytes (), baCD3/CD28+ IL-2 TK+ lymphocytes (light gray triangle), aCD3+ IL-2 TK+ lymphocytes (white square with broken line), or PBLs (X with dotted line). Medians of 8 independent experiments with 13 different donors are shown. *P < .05; **P < .01. Asterisks on aCD3+ IL-2 indicate significant differences versus all the other samples. (D) At weeks 1 and 2 after lymphocyte infusion, IL-7Rα expression was assessed on circulating human CD3+ lymphocytes. Percentages CD3+ IL-7Rα+ T lymphocytes on animals infused with baCD3/CD28+ IL-7/IL-15 TK+ lymphocytes (♦), baCD3/CD28+ IL-7 TK+ lymphocytes (), baCD3/CD28+ IL-2 TK+ lymphocytes (light gray triangle), aCD3+ IL-2 TK+ lymphocytes (white square with broken line), or PBLs (X with dotted line) were measured. Medians of 8 experiments with 13 independent donors are shown. *P < .05; **P < .01 versus aCD3+ IL-2.

Engraftment and expansion of TK+ lymphocytes in NOD/Scid mice that received a transplant of allogeneic human skin. NOD/Scid mice received a transplant of human skin (day 0), and were conditioned with anti-NK antibodies (day 10) and sublethal irradiation (day 11) prior to the intravenous infusion of TK+ lymphocytes or PBLs (day 11). TK+ lymphocytes infused to mice were transduced with optimized Mut2-SFCMM3 vector, enabling a transduction efficiency higher than 30% in all conditions. (A) Kinetics of human chimerism calculated as [% of circulating human CD3+ lymphocytes]/[(% of circulating murine CD45+ cells) + (% of circulating human CD3+ lymphocytes)] are shown. baCD3/CD28+ IL-7/IL-15 (■), baCD3/CD28+ IL-7 (), baCD3/CD28+ IL-2 (), aCD3+ IL-2 (□), or PBLs (). Medians of 8 independent experiments with 13 different donor cells are shown. *P < .05; **P < .01. WBC indicates white blood cells. (B) At weeks 1 and 2 after lymphocyte infusion, CD4/CD8 ratio was analyzed on circulating human CD3 lymphocytes. baCD3/CD28+ IL-7/IL-15 (■), baCD3/CD28+ IL-7 (), baCD3/CD28+ IL-2 (), aCD3+ IL-2 (□), or PBLs (). Averages plus or minus SD of 6 independent experiments with 11 different donor cells are shown. *P < .05. (C) At weeks 1 and 2 after lymphocyte infusion, human CD3+ lymphocytes were analyzed by flow cytometry for CD45RA and CD62L expression. Percentages of circulating human TCM (CD45RACD62L+) and TEM (CD45RACD62L) T lymphocytes were measured in mice that received a transplant of baCD3/CD28+ IL-7/IL-15 TK+ lymphocytes (♦), baCD3/CD28+ IL-7 TK+ lymphocytes (), baCD3/CD28+ IL-2 TK+ lymphocytes (light gray triangle), aCD3+ IL-2 TK+ lymphocytes (white square with broken line), or PBLs (X with dotted line). Medians of 8 independent experiments with 13 different donors are shown. *P < .05; **P < .01. Asterisks on aCD3+ IL-2 indicate significant differences versus all the other samples. (D) At weeks 1 and 2 after lymphocyte infusion, IL-7Rα expression was assessed on circulating human CD3+ lymphocytes. Percentages CD3+ IL-7Rα+ T lymphocytes on animals infused with baCD3/CD28+ IL-7/IL-15 TK+ lymphocytes (♦), baCD3/CD28+ IL-7 TK+ lymphocytes (), baCD3/CD28+ IL-2 TK+ lymphocytes (light gray triangle), aCD3+ IL-2 TK+ lymphocytes (white square with broken line), or PBLs (X with dotted line) were measured. Medians of 8 experiments with 13 independent donors are shown. *P < .05; **P < .01 versus aCD3+ IL-2.

Close Modal

or Create an Account

Close Modal
Close Modal